Claus-Michael was included in last year’s Power List. “Over the past year, in continuation of our approach to improve the delivery of drugs across biological barriers, we have expanded our focus to those barriers which are particularly relevant in the context of infectious diseases, such as immune cells, bacterial biofilms and the gram negative cellular envelope.”